XML 88 R52.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity [Abstract] |
Equity - Outstanding number of shares [Text Block] | Philips Group Outstanding number of shares
| 2021 | 2022 | 2023
--- | --- | --- | ---
Balance as of January 1 | 905,128,293 | 870,182,445 | 881,480,527
Dividend distributed | 6,345,968 | 14,174,568 | 39,334,938
Purchase of treasury shares | (45,486,392) | (5,080,693) | (15,964,445)
Delivery of treasury shares | 4,194,577 | 2,204,207 | 1,552,136
Balance as of December 31 | 870,182,445 | 881,480,527 | 906,403,156
Equity - Transactions related to share-based compensation plans [Text Block] | Philips Group Transactions related to share-based compensation plans
| 2021 | 2022 | 2023
--- | --- | --- | ---
Shares acquired | 3,996,576 | 2,142,445 | 3,000,000
Average market price | EUR 36.15 | EUR 31.76 | EUR 41.59
Amount paid | EUR 144 million | EUR 68 million | EUR 125 million
Shares delivered | 4,194,577 | 2,204,207 | 1,552,136
Average price (FIFO) | EUR 34.14 | EUR 35.16 | EUR 34.59
Cost of delivered shares | EUR 143 million | EUR 77 million | EUR 54 million
Total shares in treasury at year-end | 5,726,708 | 5,664,946 | 7,112,810
Total cost | EUR 201 million | EUR 191 million | EUR 262 million
Equity - Transactions related to capital reduction [Text Block] | Philips Group Transactions related to capital reduction
| 2021 | 2022 | 2023
--- | --- | --- | ---
Shares acquired | 41,489,816 | 2,938,248 | 12,964,445
Average market price | EUR 36.22 | EUR 36.61 | EUR 37.25
Amount paid | EUR 1,503 million | EUR 108 million | EUR 483 million
Cancellation of treasury shares (shares) | 33,500,000 | 8,758,455 | 15,134,054
Cancellation of treasury shares (EUR) | EUR 1,216 million | EUR 299 million | EUR 566 million
Total shares in treasury at year-end | 7,989,816 | 2,169,609 |
Total cost | EUR 287 million | EUR 83 million |
Equity - Composition of net debt and group equity [Text Block] | Philips Group Composition of net debt and group equity in millions of EUR unless otherwise stated
| 2021 | 2022 | 2023
--- | --- | --- | ---
Long-term debt | 6,473 | 7,270 | 7,035
Short-term debt | 506 | 931 | 654
Total debt | 6,980 | 8,201 | 7,689
Cash and cash equivalents | 2,303 | 1,172 | 1,869
Net debt | 4,676 | 7,028 | 5,820
Shareholders' equity | 14,438 | 13,249 | 12,028
Non-controlling interests | 36 | 34 | 33
Group equity | 14,475 | 13,283 | 12,061
Net debt and group equity ratio | 24:76 | 35:65 | 33:67
Equity - Adjusted income from continuing operations attributable to shareholders [Text Block] | Philips Group Adjusted income from continuing operations attributable to shareholders 1) in millions of EUR
| 2021 | 2022 | 2023
--- | --- | --- | ---
Net income | 3,323 | (1,605) | (463)
Discontinued operations, net of income taxes | (2,711) | (13) | 10
Income from continuing operations | 612 | (1,618) | (454)
Income from continuing operations attributable to non-controlling interests | (4) | (3) | (2)
Income from continuing operations attributable to shareholders1) | 608 | (1,622) | (456)
Adjustments for: |  |  |
Amortization and impairment of acquired intangible assets | 322 | 363 | 290
Impairment of goodwill | 15 | 1,357 | 8
Restructuring costs and acquisition-related charges | 95 | 202 | 381
Other items: | 1,069 | 925 | 1,358
Respironics litigation provision |  |  | 575
Respironics field-action connected to the proposed consent decree | 719 | 250 | 363
Respironics field-action running remediation cost | 94 | 210 | 224
Quality remediation actions | 94 | 59 | 175
R&D project impairments |  | 134 |
Portfolio realignment charges |  | 109 |
Impairment of assets in S&RC |  | 39 |
Provision for public investigations tender irregularities |  | 60 |
Provision for a legal matter |  |  | 31
Investment re-measurement loss |  |  | 23
Loss (gain) on divestment of business | 76 |  | (35)
Remaining items | 87 | 63 | 2
Net finance income/expenses | (84) | (4) | 18
Tax impact of adjusted items and tax only adjusting items | (527) | (376) | (450)
Adjusted Income from continuing operations attributable to shareholders1) | 1,497 | 845 | 1,148
1)Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.

X
- References No definition available. + Details
Name: | ifrs-full_EquityAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityAdjustedIncomeFromContinuingOperationsAttributableToShareholdersTextBlock
Namespace Prefix: | phg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityCompositionOfNetDebtAndGroupEquityTextBlock
Namespace Prefix: | phg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityOutstandingNumberOfSharesTextBlock
Namespace Prefix: | phg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityTransactionsRelatedToCapitalReductionTextBlock
Namespace Prefix: | phg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityTransactionsRelatedToShareBasedCompensationPlansTextBlock
Namespace Prefix: | phg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration